UA113716C2 - IMIDASOTRIAZINES AND IMIDASOPIRIMIDINS AS KINASE INHIBITORS - Google Patents

IMIDASOTRIAZINES AND IMIDASOPIRIMIDINS AS KINASE INHIBITORS

Info

Publication number
UA113716C2
UA113716C2 UAA200906353A UAA200906353A UA113716C2 UA 113716 C2 UA113716 C2 UA 113716C2 UA A200906353 A UAA200906353 A UA A200906353A UA A200906353 A UAA200906353 A UA A200906353A UA 113716 C2 UA113716 C2 UA 113716C2
Authority
UA
Ukraine
Prior art keywords
kinase inhibitors
imidasotriazines
imidasopirimidins
imidazo
kinase
Prior art date
Application number
UAA200906353A
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/085100 external-priority patent/WO2008064157A1/en
Publication of UA113716C2 publication Critical patent/UA113716C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Даний винахід стосується імідазо[1,2-b][1,2,4]триазинів і імідазо[1,2-а]піримідинів і їх фармацевтичних композицій, які є інгібіторами кіназ, таких як c-Met, і можуть бути використані в лікуванні раку і інших захворювань, пов'язаних з дизрегуляцією кіназних шляхів.The present invention relates to imidazo [1,2-b] [1,2,4] triazines and imidazo [1,2-a] pyrimidines and their pharmaceutical compositions, which are kinase inhibitors, such as c-Met, and can be used in treatment of cancer and other diseases associated with dysregulation of kinase pathways.

UAA200906353A 2006-11-22 2007-11-19 IMIDASOTRIAZINES AND IMIDASOPIRIMIDINS AS KINASE INHIBITORS UA113716C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86084006P 2006-11-22 2006-11-22
PCT/US2007/085100 WO2008064157A1 (en) 2006-11-22 2007-11-19 Imidazotriazines and imidazopyrimidines as kinase inhibitors

Publications (1)

Publication Number Publication Date
UA113716C2 true UA113716C2 (en) 2017-03-10

Family

ID=47915799

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200906353A UA113716C2 (en) 2006-11-22 2007-11-19 IMIDASOTRIAZINES AND IMIDASOPIRIMIDINS AS KINASE INHIBITORS

Country Status (1)

Country Link
UA (1) UA113716C2 (en)

Similar Documents

Publication Publication Date Title
EA200970501A1 (en) IMIDAZOTRIASINS AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS
CL2008001745A1 (en) Compounds derived from imidazo [1,2-a] pyrazine; pharmaceutical composition; and use of the compounds as protein kinase inhibitors in the treatment of cancer.
MX2009010728A (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors.
MX2009006706A (en) Bicyclic heterocyclic compounds as fgfr inhibitors.
ZA201100526B (en) Triazolo [4,5-d]pyramidine derivatives and their use as purine receptor antagonists
ECSP088906A (en) PIRAZOLO 1,5-a PYRIMIDINS
HK1116349A1 (en) Pyrrolopyrimidines useful as inhibitors of protein kinase
MX2009006704A (en) New compounds.
CL2008001025A1 (en) COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] PIRIMIDINA-2,4,6,8-TETRAONA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS METABOLIC DISORDER, DYSLIPIDEMIA AND CANCER.
EA201001242A1 (en) PYRROLO [2,3-d] Pyridine and THEIR APPLICATION AS THYROZINKINASE INHIBITORS
MX2009012066A (en) Substituted imidazopyridazines as pi3k lipid kinase inhibitors.
MX2009004771A (en) Tricyclic heteroaryl compounds useful as inhibitors of janus kinase.
ATE424402T1 (en) IMIDAZOPYRIDINE COMPOUNDS
GT201000082A (en) PIRROLO DERIVATIVES [2,3-D] PYRIMIDINE AS INHIBITORS OF KINASE PROTEINS B
DE602007007985D1 (en) AS INHIBITORS OF PROTEIN KINASES SUITABLE AMINO-PRIMIDINES
CL2011001215A1 (en) Compounds derived from pyrimidine, tyrosine kinase inhibitors; pharmaceutical compositions comprising them; and its use in the treatment and / or prevention of cancer, inflammatory diseases and autoimmune diseases.
EA201290878A1 (en) IMIDAZO [1,2-a] DERIVATIVES AND THEIR APPLICATION FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS
CL2011000489A1 (en) Compounds derived from pyrimido [5,4-d] pyrimidine, which act as tyrosine kinase inhibitors; and pharmaceutical compositions that comprise them, useful in the treatment of diseases characterized by excessive or abnormal cell proliferation
MX2009004623A (en) Imidazopyridazines as pi3k lipid kinase inhibitors.
MX2009010127A (en) N-heterocyclic compounds useful as inhibitors of janus kinases.
CL2011000116A1 (en) Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
MX2009002842A (en) HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF.
ATE502935T1 (en) C-MET PROTEIN KINASE INHIBITORS
EA201070195A1 (en) DERIVATIVES 1,2,3,4-TETRAGIDROPYRROLO [1,2-A] PIRAZIN-6-CARBOXAMIDES AND 2,3,4,5-TETRAHYDROPYRROLO [1,2-a] [1,4] -DIAZEPIN-7-CARBOXAMIDES , THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
ATE507218T1 (en) BENZODIAZEPINE DERIVATIVES AS ROCK KINASE INHIBITORS